Presentation is loading. Please wait.

Presentation is loading. Please wait.

12341234 Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text.

Published byAngelica Wilkins Modified over 8 years ago

Similar presentations

Presentation on theme: "12341234 Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text."— Presentation transcript:

1 12341234 Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text.

2 Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Communities or affiliates, or any organization with which the presenter is employed or affiliated. For work prepared by US government employees representing their agencies, there is no copyright and these work products can be reproduced freely. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners. 2

3 3 Content: (Create presentation information here) Minimum recommended font size of 28 Maximum recommended number of lines to be displayed per page is 8 Keep information on the screen and away from the edges. File Naming Criteria: Keep it short, no slashes or commas etc.: Smith_J_reference_v1 Title Text

4 Thank you Presenter Name Title Organization Your Twitter Handle Join the conversation #dia2014 4

Download ppt "12341234 Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text."

Similar presentations

Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.

Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.
Data Monitoring Models and Adaptive Designs: Some Regulatory Experiences Sue-Jane Wang, Ph.D. Associate Director for Adaptive Design and Pharmacogenomics,

Data Monitoring Models and Adaptive Designs: Some Regulatory Experiences Sue-Jane Wang, Ph.D. Associate Director for Adaptive Design and Pharmacogenomics,
Presentation Title: (Times New Roman---size:40) Author’s Name: …. (Affiliation)(Times New Roman---size:22) 1-2 Dec. 2014 Kish Island - Iran 4 th International.

Presentation Title: (Times New Roman---size:40) Author’s Name: …. (Affiliation)(Times New Roman---size:22) 1-2 Dec Kish Island - Iran 4 th International.
MOTOROLA and the Stylized M Logo are registered in the US Patent & Trademark Office. All other product or service names are the property of their respective.

MOTOROLA and the Stylized M Logo are registered in the US Patent & Trademark Office. All other product or service names are the property of their respective.
Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.
Introduction to Drug Rediscovery John Lisman Attorney-at-law Lisman Legal Life sciences Insert your logo in this area then delete this text box.

Introduction to Drug Rediscovery John Lisman Attorney-at-law Lisman Legal Life sciences Insert your logo in this area then delete this text box.
GILLINGS SCHOOL OF GLOBAL PUBLIC HEALTH Insert date here Title of presentation goes here Example image.

GILLINGS SCHOOL OF GLOBAL PUBLIC HEALTH Insert date here Title of presentation goes here Example image.
How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.

How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.
Click to add Presentation Title Arial 32, 5 line max title space line 3, title space line 4, title space line 5 Presenter Title Organization Insert your.

Click to add Presentation Title Arial 32, 5 line max title space line 3, title space line 4, title space line 5 Presenter Title Organization Insert your.
Bayesian approach to equivalence study of medical device 1 1.

Bayesian approach to equivalence study of medical device 1 1.
Join us on Twitter: #AU2014. Class summary text goes here Class summary.

Join us on Twitter: #AU2014. Class summary text goes here Class summary.
Your group topic [SELECT ONE: Usability Analysis of miamidade.gov/ Analysis of Service Delivery] Group Member 1 Group Member 2 Group Member 3 Group Member.

Your group topic [SELECT ONE: Usability Analysis of miamidade.gov/ Analysis of Service Delivery] Group Member 1 Group Member 2 Group Member 3 Group Member.
Join us on Twitter: #AU2013.  An appropriate image has been provided for your presentation based on the AU look and feel  You can replace the Title.

Join us on Twitter: #AU2013.  An appropriate image has been provided for your presentation based on the AU look and feel  You can replace the Title.
Www.diahome.org Sherri de Coronado Enterprise Vocabulary Services NCI Center for Bioinformatics and Information Technology March 11, 2009 A Terminology.

Sherri de Coronado Enterprise Vocabulary Services NCI Center for Bioinformatics and Information Technology March 11, 2009 A Terminology.
Making Comments Count for High-Impact Regulations and Guidelines in the US Virginia (Ginny) Beakes-Read Executive Director, Global Regulatory Policy and.

Making Comments Count for High-Impact Regulations and Guidelines in the US Virginia (Ginny) Beakes-Read Executive Director, Global Regulatory Policy and.
Strategic Analyses and Interpretation: Regulatory Intelligence for Decision Making Amy N. Grant Director, Regulatory Strategy & Science ViroPharma Incorporated.

Strategic Analyses and Interpretation: Regulatory Intelligence for Decision Making Amy N. Grant Director, Regulatory Strategy & Science ViroPharma Incorporated.
Good Laboratory Practices and Inspection Readiness Paul Swidersky President/Sr. Consultant Quality Associates, Inc.

Good Laboratory Practices and Inspection Readiness Paul Swidersky President/Sr. Consultant Quality Associates, Inc.
Meredith Brown-Tuttle, RAC Director APT Pharmaceuticals, Inc.

Meredith Brown-Tuttle, RAC Director APT Pharmaceuticals, Inc.
DIA ERS SIAC IND CMC eCTD Submissions Part II – IND to NDA

DIA ERS SIAC IND CMC eCTD Submissions Part II – IND to NDA
Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.

Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.

Similar presentations

Ads by Google